Home » Topics » BioWorld Science

BioWorld Science
RSS

Xenon Pharmaceuticals tests antiepileptic NaV1.6 inhibitors in vivo

Aug. 31, 2018

Seven genes linked to plaque rupture in STEMI

Aug. 31, 2018

Novel cardiac biomarkers identified for heart failure, myocardial infarction

Aug. 31, 2018

Bristol-Myers Squibb patents receptor-interacting serine/threonine-protein kinase 1 inhibitors

Aug. 31, 2018

Pfizer terminates two ongoing domagrozumab studies for DMD

Aug. 31, 2018

Thanks for the memories: In bacteria, protein aggregates can protect from stress

Aug. 31, 2018

FDA approves Jivi for hemophilia A

Aug. 31, 2018

New preterm labor is drug safe with favorable pharmacokinetic profile

Aug. 31, 2018

PLIN2 is a putative tumor suppressor and prognostic marker of renal cell carcinoma

Aug. 31, 2018

Renin inhibitor TAK-272 developed at Takeda for heart failure

Aug. 31, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...